Insider Transactions in Q4 2024 at Guardant Health, Inc. (GH)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 01
2024
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,498
+11.06%
|
-
|
|
Oct 01
2024
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,980
-10.75%
|
$65,560
$22.12 P/Share
|
|
Oct 01
2024
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,877
+9.88%
|
-
|
|
Oct 01
2024
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,162
-14.74%
|
$91,564
$22.12 P/Share
|
|
Oct 01
2024
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,211
+22.53%
|
-
|